A detailed history of Janney Montgomery Scott LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 15,895 shares of HRMY stock, worth $537,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,895
Previous 35,369 55.06%
Holding current value
$537,886
Previous $1.07 Million 40.39%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$30.0 - $39.95 $584,220 - $777,986
-19,474 Reduced 55.06%
15,895 $636,000
Q2 2024

Jul 25, 2024

BUY
$28.81 - $33.01 $155,429 - $178,088
5,395 Added 18.0%
35,369 $1.07 Million
Q1 2024

May 01, 2024

BUY
$29.93 - $35.06 $73,777 - $86,422
2,465 Added 8.96%
29,974 $1.01 Million
Q4 2023

Feb 07, 2024

BUY
$19.2 - $33.78 $126,163 - $221,968
6,571 Added 31.38%
27,509 $889,000
Q3 2023

Nov 08, 2023

BUY
$31.89 - $39.03 $667,712 - $817,210
20,938 New
20,938 $686,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.